David Balli
David Balli
Advaxis
Bekræftet mail på fastmail.com
Titel
Citeret af
Citeret af
År
Detection of therapeutically targetable driver and resistance mutations in lung cancer patients by next-generation sequencing of cell-free circulating tumor DNA
JC Thompson, SS Yee, AB Troxel, SL Savitch, R Fan, D Balli, ...
Clinical Cancer Research 22 (23), 5772-5782, 2016
1602016
Foxm1 transcription factor is required for lung fibrosis and epithelial‐to‐mesenchymal transition
D Balli, V Ustiyan, Y Zhang, IC Wang, AJ Masino, X Ren, JA Whitsett, ...
The EMBO journal 32 (2), 231-244, 2013
1232013
EMT subtype influences epithelial plasticity and mode of cell migration
NM Aiello, R Maddipati, RJ Norgard, D Balli, J Li, S Yuan, T Yamazoe, ...
Developmental cell 45 (6), 681-695. e4, 2018
932018
Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy
J Li, KT Byrne, F Yan, T Yamazoe, Z Chen, T Baslan, LP Richman, JH Lin, ...
Immunity 49 (1), 178-193. e7, 2018
892018
Endothelial Cell–Specific Deletion of Transcription Factor FoxM1 Increases Urethane-Induced Lung Carcinogenesis
D Balli, Y Zhang, J Snyder, VV Kalinichenko, TV Kalin
Cancer research 71 (1), 40-50, 2011
622011
Immune cytolytic activity stratifies molecular subsets of human pancreatic cancer
D Balli, AJ Rech, BZ Stanger, RH Vonderheide
Clinical Cancer Research 23 (12), 3129-3138, 2017
572017
Deletion of Forkhead Box M1 transcription factor from respiratory epithelial cells inhibits pulmonary tumorigenesis
IC Wang, L Meliton, X Ren, Y Zhang, D Balli, J Snyder, JA Whitsett, ...
PloS one 4 (8), 2009
572009
Foxm1 transcription factor is required for macrophage migration during lung inflammation and tumor formation
D Balli, X Ren, FS Chou, E Cross, Y Zhang, VV Kalinichenko, TV Kalin
Oncogene 31 (34), 3875-3888, 2012
542012
Foxm1 expression in prostate epithelial cells is essential for prostate carcinogenesis
Y Cai, D Balli, V Ustiyan, L Fulford, A Hiller, V Misetic, Y Zhang, ...
Journal of Biological Chemistry 288 (31), 22527-22541, 2013
502013
Tumor immunity and survival as a function of alternative neopeptides in human cancer
AJ Rech, D Balli, A Mantero, H Ishwaran, KL Nathanson, BZ Stanger, ...
Cancer immunology research 6 (3), 276-287, 2018
282018
FOXM1 activates AGR2 and causes progression of lung adenomas into invasive mucinous adenocarcinomas
D Milewski, D Balli, V Ustiyan, T Le, H Dienemann, A Warth, K Breuhahn, ...
PLoS genetics 13 (12), e1007097, 2017
222017
An integrated flow cytometry-based platform for isolation and molecular characterization of circulating tumor single cells and clusters
N Bhagwat, K Dulmage, CH Pletcher, L Wang, W DeMuth, M Sen, D Balli, ...
Scientific reports 8 (1), 1-14, 2018
202018
Targeting frameshift mutations with a Listeria monocytogenes immunotherapy drives neoantigens-specific anti-tumor immunity in the MC38 and CT26 mouse tumor models
B Coder, D Villarreal, S Armington, E Filippova, A L’Huillier, D Kelkar, ...
Proceedings of the AACR Annual Meeting, 2018
22018
Targeting shared hotspot cancer mutations with a Listeria monocytogenes immunotherapy induce potent anti-tumor immunity
D Villarreal, B Coder, S Armington, A L’Huillier, C Mattershead, ...
Proceedings of the AACR Annual Meeting, 2018
22018
Abstract A60: Foxf1 transcription factor drives progression of benign lung adenomas to malignant adenocarcinomas
X Wang, D Balli, T Le, VV Kalinichenko, TV Kalin
Cancer Research 73 (3 Supplement), A60-A60, 2013
22013
Abstract B38: Calcium signaling induces a partial EMT in pancreatic ductal adenocarcinoma
RJ Norgard, R Maddipati, NM Aiello, D Balli, JR Pitarresi, ...
Cancer Research 79 (24 Supplement), B38-B38, 2019
2019
Immunogenic Compositions Targeting Recurrent Cancer Mutations And Methods Of Use Thereof
R Petit, MF Princiotta, B Coder, D Balli
US Patent App. 16/348,274, 2019
2019
Safety and Immunogenicity of a Personalized Neoantigen-Listeria Vaccine in Cancer Patients
JR Hecht, JW Goldman, S Hayes, D Balli, MF Princiotta, JG Dennie, ...
Cancer Research 79 (13), 2019
2019
Abstract LB-148: Targeting frameshift mutations with a Listeria monocytogenes immunotherapy drives neoantigen-specific antitumor immunity in the MC38 and CT26 mouse tumor models
B Coder, DO Villarreal, S Armington, E Filippova, A L'Huillier, D Kelkar, ...
Cancer Research 78 (13 Supplement), LB-148-LB-148, 2018
2018
Abstract LB-149: Targeting shared hotspot cancer mutations with a Listeria monocytogenes immunotherapy induce potent anti-tumor immunity
D Villarreal, B Coder, S Armington, A L'Huillier, C Mottershead, ...
Cancer Research 78 (13 Supplement), LB-149-LB-149, 2018
2018
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20